We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Lucira Health Inc | NASDAQ:LHDX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.4523 | 0.4451 | 0.448 | 0 | 01:00:00 |
By Denny Jacob
Lucira Health Inc. shares doubled in after-hours trading Friday following the Food and Drug Administration's emergency use authorization for its diagnostic test.
The FDA said it authorized the Lucira COVID-19 & Flu Test, an over-the-counter at-home test that can differentiate and detect the flu and the virus that causes Covid-19.
"The FDA strongly supports innovation in test development, and we are eager to continue advancing greater access to at-home infectious disease testing to best support public health needs," said Jeff Shuren, director of the FDA's center for devices and radiological health.
Lucira, the publicly traded maker of at-home Covid-19 testing kits, this week filed for bankruptcy, saying an easing of pandemic restrictions has lowered demand for its products. The company, which lists $145.9 million in assets and $84.7 million in debt, said Wednesday it will look for a buyer while continuing to serve customers during chapter 11 proceedings in U.S. Bankruptcy Court in Wilmington, Del.
Shares rose 113% to 30 cents in aftermarket trading. The stock, which closed up 13% to 14 cents, is down about 97% over the last 12 months.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
February 24, 2023 17:28 ET (22:28 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Lucira Health Chart |
1 Month Lucira Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions